Tizanidine Tablet
Product Images NDC 67296-2209

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 67296-2209). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular Structure (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 01)

FDA Label Image

Figure-1 (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 02)

FDA Label Image

Figure 3 (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 03)

FDA Label Image

Figure 4 (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 04)

This text provides information about the improvement in Ashworth score over time, with specific mention of the mean dose used. It indicates the timing of assessments at the end of titration (Study Week 3), end of maintenance (Study Week 7), and the endpoint using the Last Observation Carried Forward method.*

FDA Label Image

Logo (Ee6ccf71 79ba 43ca 9a1a 1cab1d5a0c6c 05)

FDA Label Image

Container Label (Tizanidine tablets 2 mg)

Each tablet of Tizanidine hydrochloride contains 2.288 mg of the active ingredient. The usual dosage information is available in the accompanying literature. Store the tablets at a temperature range of 20°C to 25°C (68°F to 77°F) in a tight, light-resistant container. This medication is manufactured by UNICHEM LABORATORIES LTD. in India and is dispensed by UNICHEM PHARMACEUTICALS (USA), INC. Remember to keep this and all medications out of reach of children.*

FDA Label Image

Container Label (Tizanidine tablets 4 mg)

This text provides information about a tablet containing 4,576 mg of tizanidine hydrochloride, with instructions on the usual dosage and storage conditions. It emphasizes keeping the medication out of reach of children and highlights that Tizanidine Tablets are not interchangeable with Tizanidine Capsules. The manufacturing details of the tablet are also mentioned, indicating it is produced by UNICHEM LABORATORIES LTD in Goa, India, and manufactured for UNICHEM PHARMACEUTICALS (USA), INC. in East Brunswick, NJ. The total number of tablets in the container is 150.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.